Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
#35 on petition...I love the boycott idea and will cover the whole entire net with this event....!
rager
re ETCR, Skeena and all, you see this?
NEW YORK -(Dow Jones)- A broker at Joseph Stevens & Co. impersonated clients over the phone to liquidate their accounts and use the proceeds to manipulate penny stocks, the Securities and Exchange Commission alleges in a lawsuit.
Robert C. Ingardia, 25, of Plainview, N.Y., also faces related criminal securities fraud charges. He was terminated from Joseph Stevens Thursday.
Authorities say Ingardia called up six brokerages where his clients and former clients held accounts, and, while pretending to be those clients, gave orders to sell holdings totaling more than $1.1 million.
He then used the proceeds to buy large blocks of Equity Technologies & Resources Inc. (ETCR) and Converge Global Inc. (CVRG), two over-the-counter Bulletin Board companies with thinly-traded stocks, the SEC said.
Juan Marcel Marcelino, district administrator with the SEC's Boston office, said Ingardia supplied information such as birth dates, addresses and Social Security numbers when asked.
"He apparently knew enough of the identifying information that a brokerage firm would customarily ask a customer," Marcelino said.
In one case, Ingardia allegedly targeted a Joseph Stevens client who maintained a separate account at Fidelity Brokerage Services. While the client was on vacation, Ingardia called Fidelity and liquidated $450,000 in securities holdings from his account, the SEC said.
Ingardia could not be immediately located for comment. Jeff Lederer, the president of Joseph Stevens, said the charges against Ingardia "had nothing to do with his employment at Joseph Stevens."
The SEC said Ingardia worked with others to purchase blocks of Equity Technologies and Converge Global and cause "successively rising prices of the two stocks." The agency declined to name Ingardia's alleged cohorts, but noted that its investigation is continuing.
The SEC's suit, filed Thursday in Manhattan federal court, seeks an order requiring Ingardia to return alleged illegal profits and pay a civil penalty.
A related criminal complaint filed by the Manhattan U.S. Attorney's Office charges Ingardia with eight counts of securities fraud.
-By Colleen DeBaise, Dow Jones Newswires; 212-227-2017; colleen.debaise@ dowjones.com
(This story was originally published by Dow Jones Newswires)
Copyright (c) 2001 Dow Jones & Company, Inc.
All Rights Reserved
Copyright (C) 2001 Dow Jones & Company, Inc. All Rights Reserved.
if GM had kept up with the technology....>
this is from spiel's board but had to share...
> >At a recent computer expo (COMDEX), Bill Gates reportedly compared the
> >computer industry with the auto industry and
> >stated, "if GM had kept up with the technology like the computer
> >industry has, we would all be driving $25.00 cars that got 1,000
> >miles to the gallon." In response to Bill's comments, General Motors
> >issued a press release stating:
> >
> >If GM had developed technology like Microsoft; we would all be
> >driving cars with the following characteristics:
> >
> >1. For no reason whatsoever, your car would crash twice a
> >day.
> >
> >2. Every time they repainted the lines in the road, you would have
> >to buy a new car.
> >
> >3. Occasionally your car would die on the freeway for no reason.
> >You would have to pull over to the side of the road, close all of the
> >windows, shut off the car, restart it, and reopen the windows before you
> >could continue. For some reason you would simply accept this.
> >
> >4. Occasionally, executing a manoeuvre such as a left turn would
> >cause your car to shut down and refuse to restart, in which case you
> >would
> >have to reinstall the engine.
> >
> >5. Only one person at a time could use the car unless you bought
> >"CarNT",
> >but then you would have to buy more seats.
> >
> >6. Macintosh would make a car that was powered by the sun,
> >was reliable, five times as fast and twice as easy to drive-but would
> >only
> >run on five percent of the roads.
> >
> >7. The oil, water temperature, and alternator warning lights
> >would all be replaced by a single "General Protection fault" warning
> >light.
> >
> >8. New seats would force everyone to have the same sized
> >butt.
> >
> >9. The airbag system would ask, "are you sure?" before
> >deploying.
> >
> >10. Occasionally, for no reason whatsoever, your car would
> >lock you out and refuse to let you in until you simultaneously lifted
> >the
> >door handle, turned the key and grabbed hold of the radio antenna.
> >
> >11. GM would require all car buyers to also purchase a deluxe set of Rand
> >McNally road maps (now a GM subsidiary) even though they neither need
> >nor
> >want them. Attempting to delete this option would immediately cause the
> >car's performance to diminish by 50% or more. Moreover, GM would become
> >a
> >target for investigation by the Justice Dept.
> >
> >12. Every time GM introduced a new car, car buyers would
> >have to learn to drive all over again because none of the controls would
> >operate in the same manner as the old car.
> >
> >13. You'd have to press the "Start" button to turn the engine off.
any thoughts on GENI 3 for 1 stock split news ..em
fwiw Salon.com (SALN) is being mentioned in rumors on internet message boards. The company's stock has been languishing for several months now, and sits at .40 per share. A delisting from the Nasdaq is looming and the overall dot-com outlook has not been good. It is rumored that they will engineer a 20:1 reverse stock split to try and turn all of this around. The company has not commented on this publicly.
heads up on TFSM..24/7 Media May Seek Reversal
By Andrew Morse
In an effort to avoid delisting, the interactive marketing firm is considering a reverse stock split.
(The Industry Standard)
Interactive marketing firm 24/7 Media announced Wednesday that it would ask shareholders for permission to reduce the amount of its outstanding common stock in an effort to boost the company's share price and retain its listing on the Nasdaq National Market.
The company said it was considering a reverse stock split, a technique companies often use to boost sagging share prices. In a reverse stock split, shareholders would receive one share of the company's stock in exchange for a set amount of outstanding shares.
New York-based 24/7 is considering a reverse split because its shares have been trading below $1 since March, breaching one of the thresholds set by the Nasdaq for a potential delisting. Like many Web companies, 24/7 Media has seen revenues shrink amid a slump in advertising and has been hurt by the overall collapse of Internet shares.
Proxy statements will be sent to shareholders in about two weeks, according to a 24/7 press release. 24/7 Media's shares fell two cents, or 12 percent, to 15 cents in Nasdaq trading. The company's 52-week high is $14.25.
Good morning all, see NCNT getting attention...fwiw..em
sheesh WLDI .011 X .03 what a joke...em
News for ZKEM...;)------>
Xechem International, Inc. Receives a Mexican Patent With Claims Covering Its
Novel Paclitaxel
Extraction and Purification Processes
Business Editors
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--September 4, 2001--Xechem
International, Inc. (OTC BB ZKEM) today announced that it has received
a Mexican patent for its novel and efficient proprietary technology to
extract and purify paclitaxel from the Yew tree (Taxus brevifolia and
other Taxus species).
The claims cover the method of extraction and purification from
raw biomass and more refined paclitaxel-containing sources. The method
is simple, novel and provides a high yield of paclitaxel from
renewable sources without destroying or endangering existing natural
sources of paclitaxel, which has been a serious concern in the past.
Paclitaxel is the generic name of Taxol(R) (Bristol-Myers Squibb)
which is used for the treatment of ovarian, breast, small-cell lung
and stomach cancers and AIDS related Kaposi Sarcoma.
Xechem has also developed several new analogs of paclitaxel and
processes for their production for which it is seeking patent
protection internationally (patents pending). These novel analogs have
displayed anticancer efficacy with broad therapeutic index against an
array of tumor cells in the preliminary animal models.
Based on the publicly available information, the existing market
of paclitaxel is greater than $2 billion dollars. Xechem currently has
regulatory approval to sell its generic paclitaxel product in India
and is aggressively seeking regulatory approval other countries
including North and South America.
Xechem International, Inc., (www.xechem.com) headquartered in New
Brunswick, NJ, with subsidiary companies in USA, India and joint
venture partners in both Hong Kong and Peoples Republic of China, is a
biopharmaceutical company of which Xechem, Inc. (a US subsidiary) is
engaged in the research, development and production of generic and
proprietary drugs from natural sources, specializing in the
development of niche-generic, difficult to replicate anticancer,
antiviral (including Human Immuno-deficiency Virus, HIV), antifungal
and anti-infective compounds and screens extracts and pure compounds
from various parts of the world for their therapeutic use. XetaPharm,
Inc., a subsidiary of Xechem, develops quality controlled nutritional
products such as GinkgoOnce(R), GinsengOnce(R), GarlicOnce(R),
Gugulon(TM), Co-Enzyme Q-10 and VIDA PRAS(TM) as well as numerous
other products under development. All XetaPharm products can be seen
and ordered from our website at www.xetapharm.com, at our toll-free
number (1-800-858-5854) or through a growing number of pharmacies,
health food and nutritional stores.
-0-
This news release contains certain forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, which are intended to be covered by safe harbors created
hereby. Such forward-looking statements involve known and unknown
risks, uncertainties, including the ability of the Companies to
successfully develop and commercialize their technologies, and other
factors that may cause the actual results, performance or achievements
of the Companies to be materially different from any future results,
performance or achievements of the Companies expressed or implied by
such forward-looking statements.
--30--emb/ny*
CONTACT: Xechem International, Inc., New Brunswick
John P. Luther, 732/247-3300
KEYWORD: NEW JERSEY
INDUSTRY KEYWORD: ALTERNATIVE MEDICINE BIOTECHNOLOGY MEDICAL
PHARMACEUTICAL
SOURCE: Xechem International, Inc.
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: http://www.businesswire.com
fwiw SKVY news abour financing................
http://biz.yahoo.com/prnews/010904/nytu089.html
fwiw Endovasc and Intermed 2000 Announce Merger..ENDV news...
http://biz.yahoo.com/prnews/010903/lnm001a.html
Yes Patsy thread, so on to a good trading day all...em
Speaking of heads up, this is worth the read...
http://www.onthecanvas.com/newest_addition_to_permeating.htm
also this from Capelouto on RB,
PLEASE FOCUS ON THE TWO THINGS THAT WILL HELP US: Here is the updated list of "PERPS" that lead to authorities helping our problem.
Information leading to the arrest and conviction of perpousfull stock defrauding of an investor inthe pursuit of investing funds into a publicly traded security
"IS PUNISABLE BY LAWS SETFORTH BY THE SEC."
NAMES HAVE BEEN ADDED TO THE LIST OF PEOPLE BEING INVESTIGATED BY SHAREHOLDERS, PLEASE NOTE ADDITIONS:
ROY MEADOWS: KINGPIN OF ORGANIZATION
MEADOWS ROY YES they even have stuff in reverse order
DAVID MEADOWS: BROTHER TO ROY RUNS HUNTER DEVELOPMENT. REAL ESTATE EMPIRE
LINDA MEADOWS: OF COURSE ROYS WIFE. SHE HAS CORPS TOO
JIM MEADOWS: SON OF ROY MEADOWS OWNER JIM STOCWELL COMPANIES
DONALD A. MITCHELL: IIBI INVESTMENT BANKING FIRM THAT CANT RAISE ANY MONEY BUT CERTAINLY KNOWS HOW TO STEAL IT!!! YOU TICKET.COM, DIVE DEPOT, BASKININ THE SUN
ALIAS MITCHELL DON Lots of stuff in reverse order. THESE GUYS ARE GOOD AT THIS. TIES TO MSITF and RON TALBOT
CARL E DILLEY: LONG TIME LINK WITH DONALD MITCHELL TO MARC HARRIS ORGANIZATION. ACTING AS PUPPET OPERATING EREX, INC.
MARC JABLON: OPERATES BIG APPLE CONSULTING FRONT FOR ROY MEADOWS
JABLON MARC: DIRECT PROTEGE OF ROY MEADOWS. BROUGHT UP AS RETAIL FILL-IN AFTER BOUY CLUB INCIDENT ROCKS STOCKBROKER PRESENTATIONS FRONT and CHANGES NAME TO BAC.
MATTHEW MAGUIRE: BAC OPERATIVE IN BOILER ROOM ACTING AS MGR. SHOULD BE SCARED ROY'S AFTER HIM
ANGELA BORDWELL: FRONTS FOR ROY MEADOWS PRESENTLY WORKING DCIH
ALIAS ANGELA ZUCHINNI: ALIAS USED TO COLLECT CHECKS AND ACCTS IN FALSE NAME
JEFFERY HARVEY: NUMEROUS DIRECTOR POSITIONS IN MEADOWS AND MITCHELL OPERATIONS
ALIAS HARVEY JEFFERY: REVERESES NAME TO HIDE BUT IS CAUGHT ANYWAY
ELLIOT PESARSON: RETAIL PROMOTER PAID IN STOCK TO PUMP
BYRON RAMBO: NUMEROUS DIRECTOR OPERATIVE IN NAME ONLY FOR ROY MEADOWS AND DONALD MITCHELL COMPANIES/ ANOTHER FLUNKY
DANIEL BALDRIDGE: FORMER EMPLOYEE OF WORLDVISION NOW CALL ROOM MGR OF OPERATIONS AT BAC
KENNETH H. BLAKE: ALIAS FRONT FOR ROY MEADOWS AND DONALD MITCHELL COMPANY DIRECTOR POSITIONS
RON GOODING: ALIAS IIBI FLUNKY. MITCHELL USED HIS NAME
RICK FELLOWS: ROY MEADOWS ASSOCIATE IN KNGS DEBAUCLE
CRYSTAL GIONNAZO: ALIAS ROY'S GIRLTOY/ CRYSTAL MANAGEMENT RESOURCES
DONNIE PLATTON: ALIAS BOILER ROOM MAN IN ASSOC W/DCIH
DONNY LOVE: Probably an alias for the above. INVOLVED IN ASSOC WITH ROY MEADOWS IN IR FIRM ALEXANDER GRANT and COX
RAN BOILER ROOM PUMPING FRCD and PRXX
SCOTT GNATT: ALIAS ANOTHER BOILER ROOM OPERATOR
J.D. DISMUKE: ALIAS THE CLEANER. I THINK THIS GUY IS THE REALLY NICE GUY IN ALL THIS??? BUT WHAT DO YOU THINK HE CLEANS UP?????
POSSIBLE COMPANIES INVOLVED----------
JAMES STOCKWELL, INC.
INTERNATIONAL INVESTMENT BANKING,INC.
BIG APPLE CONSULTING, INC.
STOCKBROKER PRESENTATIONS,INC.
STOCKBROKER RELATIONS,INC.
GRANT DOUGLAS CORPORATION,INC.
STOCKBROKER PRESENTATIONS of COLORADO,INC.
CRYSTAL MANAGEMENT RESOURCES, INC.
BORDWELL FINANCIAL GROUP, INC.
AIRAM FINANCIAL INVESTMENTS, INC.
AQUISITION CAPITOL, CORP.
ACQUISITION ASSOCIATES, INC.
CAPITOL INNOVATIONS, INC.
PALM TREE PROMOTIONS, INC.
WCDA CAPITOL CORP.
All of the above have been turned over to the FBI and SEC for investigation. MORE TO FOLLOW!!!!!!!!!!!!!!!!!!!!!!!!
'Georgia Bard' Thanks for the heads up, YGM..em
Hello spiel, good to see you here...!
I am holding lots of ZKEM and like it fwiw..em
heads up on CUPR--->
fwiw....this from the RB board
By: north42 $$$
Reply To: None Tuesday, 28 Aug 2001 at 10:57 AM EDT
Post # of 23
*** NEWS ALERT
This is it folks - CUPR to trade on OTCBB beginning next week. Just the first step. Expect MAJOR news as soon as stock is OTCBB available. IMO, get in while it's on the pinks so you capture the BB spike. This is not a drill!
north
who loves ya?... rager
WWWN getting interest again...thoughts?
thought on RWKS?...eom
fwiw, KMAG files for chapter 11 ..em
fwiw in ENDV now, some info....
ENDV...some info
52-week Range
0.0460 - 1.4688
float before settlement 8 mil
About the Company
Endovasc Ltd. Inc. is a biopharmaceutical/biotech company pioneering liposomal drug delivery technology. The Company's products and processes, which include Liprostin(TM) (liposome encapsulated PGE-1), NRA (Nicotine Receptor Agonist, angiogenesis agent), stent-coating technology, and a biodegradable/resorbable stent are covered by patents, license and trade secrets for competing in a multi-billion dollar market.
settlement of law suit
http://biz.yahoo.com/bw/010817/172274.html
float before settlement 8 mil
250K of ZKEM for me, next week should be a good one, IMO.em
IMO, ZKEM is a good buy at these levels...notice
I do not like folks to get hurt in the markets
and do not like spamming...but will add that I have had a convesation today with a contact at ZKEM and glad I own this stock. just thought to share with the best board on the web.
Jeff
ps do not buy anything with out doing your DD
BB, re ARYN
That is why I position trade...didnt have to chase the ask
pulled out at 300%
again MFLM pulled 50% last month on 1 mil
sure they are all POS's but thats where the runners are IMO
Jeff
ok BB heres a low floater for ya.......
SCAN VEC COMPANY SVECF
problem being is its so low it doesn't barely trade
now if I was a momo player...hmmmm
Good News for ARYN-->
Archer Acquires Ocumed Group, Inc.
ROSELAND, N.J.--(BUSINESS WIRE)--Aug. 16, 2001--Archer Systems Limited Inc (otc bb:ARYN - news) today announced that it had acquired 100% of the capital stock of Ocumed Group, Inc.
Based in Roseland, Ocumed is a privately held, specialty pharmaceutical company which has been manufacturing and distributing sterile ophthalmic solutions and related products since 1986.
The acquisition involves an exchange of a combination of shares of Archer's restricted common stock and subordinated promissory notes for all Ocumed's outstanding common stock. Ocumed Group Inc. will operate as a wholly-owned subsidiary of Archer. Ocumed's management team, headed by Alfred R. Caggia, its Chairman and CEO and Paul G. Filipek, Ocumed's Treasurer and CFO were named as President and CEO and Secretary/Treasurer and CFO of Archer respectively. They have assumed operating and financial control of Archer.
Ocumed produces and sells a broad range of ophthalmic products for both the prescription (``Rx'') and over-the-counter (OTC) pharmaceutical markets. These products support lens care and eye care as well as diagnostic, surgical and therapeutic ophthalmic applications.
Ocumed's manufacturing and distribution facilities consist of over 35,000 sq. ft. of sterile manufacturing and laboratory operations in Roseland and Sarasota, FL., together with 10,000 sq. ft. of warehousing and administrative offices including decentralized packaging and distribution facilities located throughout the United States and Canada. Ocumed recorded sales of $5.6 million as reported in its 2000 year-end audited statements, reflecting an increase over previous year's results of $4.5 million in sales.
Ocumed markets and distributes its branded product lines nationally through major drug chains, wholesalers, hospitals, surgi-centers and related buying groups as well as internationally to selective markets. Ocumed's products are focused on a group of patented and proprietary drug delivery systems for applications in surgery, diagnostics, therapy, and lens care in the ophthalmic field. These product lines include; OPHTHA-DOSE P.F.(TM) a preservative free unit of use dispenser for eye drops, OCUREST(TM), a patented multi-dose dispenser for prescription (Rx) and over-the-counter (OTC) ophthalmic applications, and MINI-MED(TM), a controlled dispenser system for delivering highly accurate quantities of drugs.
According to Archer's new management team, ``This acquisition is the first and most important step in our business strategy to grow the company and increase shareholder value. This new corporate structure offers Ocumed a powerful currency that enables us to expand an already established business. We expect, as a public company, to have better access to the capital markets. In addition, Ocumed has identified and targeted several business opportunities that we can now incorporate into our over all expansion and acquisition strategy and further accelerate the growth and value of our company,''
SAFE HARBOR
This release may contain forward-looking statements or inferences that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of l995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to differ materially from forecast results. A number of factors, including availability of sufficient capital, inflation, demand for ophthalmic products, interest rates and absence of labor disputes could adversely affect the Company's ability to obtain these results. Certain of these risks may be described in the Company's filings with the Securities and Exchange Commission (``SEC''). Copies of the Company's SEC filings are available from the SEC or may be obtained upon request from the Company. The Company does not undertake any obligation to update the information contained herein which speaks only as of this date.
--------------------------------------------------------------------------------
Contact:
Ocumed Group, Inc.
Alfred Caggia
Paul Filipek
(973) 226-2330
or
Richard E. Spencer
Investor/Shareholder
Communications
(888) 321-8922
dont own it (yet) but ARCH could be interesting this A.M....em
RTNN, MM's killed it with that spread after I bought (sob's)
next...Back in RNTT...fwiw...;)
TVCP, as a position trader I bought this last week and
as I see it the MM's will let her run for an easy double soon.
In reading the financials I see them as being in a better position then when I sold the bugger for $3.75 ggg
this is IMO, rager
fwiw, back in WWWN myself ;)...eom
PAPO movin on up on low volume, anyone know this stock?
bb_stock', fwiw CUPR starting to trade, not a reco but keep your eye on it, :0)
Jeff
bb_stock' that DCTG not DPCI I mentioned TIA
i like BB,
any opine on the volume of ENDV?
also any word out there on DCTG? getting some volume today
appreciate your input
Jeff
Buzz, fwiw flipped all my WWWN @.068 yesterday figured the same as you that re-entry was going to be cheaper.
fingers crossed lol
Jeff
VERC Announces Forward Stock Split ...>
August 09, 2001 13:34
VersaCOM International Announces Forward Stock Split
BOCA RATON, Fla., Aug. 9 /PRNewswire/ -- VersaCOM International Inc.'s (OTC Bulletin Board: VERC) Board of Directors unanimously approved a 1.2 for one forward split of its outstanding shares. The split is effective August 20, 2001, and requires a mandatory exchange of stock certificates to receive the dividend shares, Fred Schwartz, Chief Executive Officer and President of VersaCOM, announced today.
"We see this as an opportunity to increase the number of available shares in the market and to reward our company shareholders with a greater number of shares," said Schwartz. "Our business prospects should quickly escalate the company's growth, and that growth should, in turn, be reflected in our share value."
"We approved this, in part, to ensure that all our currently trading shares are in fact authorized and appropriately backed by the required certificates," explained Schwartz.
Certificate(s) should be forwarded to Atlas Stock Transfer, 5899 South State Street, Murray, Utah 84107, together with a check in the amount of $15 for each certificate (not each share) for each new certificate to be issued. If you request that your shares be issued to some other person or entity, please ensure that your certificate has been signed and "Medallion" guaranteed. Most brokers and commercial banks can provide this service.
VersaCOM International, Inc. is a Boca Raton, Florida based full-service provider of telecommunications systems, data networks and related products and services throughout the United States. In addition to designing, distributing, installing and programming telecommunications and data systems, VersaCOM offers cabling, training, product customization and 24 x 7 customer support and maintenance. VersaCOM also markets local and long distance communications services as an authorized BellSouth partner and a reseller for Cable and Wireless. Lastly, VersaCOM's technicians and engineers provide on-site system/network administration and other technical support. VersaCOM specializes in providing voice and data solutions to companies with more than one business location. These companies have special needs for consistent, responsive services.
VersaCOM International, Inc. was incorporated in Florida in January 1999. In addition to the corporate headquarters in Boca Raton, the company has regional operations in the Baltimore-Washington metropolitan area and the New York-New Jersey metropolitan area, Winter Garden, FL serving Orlando and central Florida and southern Maine serving the New England states. It also employs a Vice President of Marketing in Southern California. For more information on VersaCOM International's products and services, please see their web site at: www.versacominc.com
This press release contains certain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on management's current expectations of beliefs and are subject to a number of factors and uncertainties that could cause actual results, levels of activity, performance or achievements to differ materially from those described.
MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X45110354
SOURCE VersaCOM International, Inc.
/CONTACT: Arnold Hoffman, Director of Marketing of VersaCOM
International, Inc., +1-800-531-1577 ext. 1254/
/Web site: http://www.versacominc.com /
(VERC)
i_like_bb,
only thing wrong I can find re your ENDV post is you state...
that's what makes this board so nice.
actually that's what makes this board The Best...!
thanks again.
Jeff
Thanks BB...eom
look at ENDV, 52 week low been nibbling, do your DD..EM